| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e3b76a01728ea47f5e574b71ce6e73da |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61F2310-00365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2430-40 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3683
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3687
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3695
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-3604
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-24 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61F2-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L27-36 |
| filingDate |
1998-11-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9599b6eff042312600e09b5bdf38aa7f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1a63ab5bba8a83a868a2af41bbae1925
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_25d6e4566899b968e898308a90d315a2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d6a1f70d96feb6c119de8876ecd0aacd |
| publicationDate |
2001-08-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1035877-B1 |
| titleOfInvention |
Method for inhibiting calcification of aldehyde-fixed bioprosthetic materials |
| abstract |
A method for preparing collagenous biological tissues for use as implantable bioprosthetic material, and articles prepared thereby. The method generally comprises the steps of a) contacting the tissue with an aldehyde fixative to effect cross-linking of the connective tissue protein(s) and subsequently b) contacting the tissue with a polyglycidyl ether. The treatment of the crosslinked tissue with the polyglycidyl ether serves to mitigate the tissue's propensity to undergo calcification following implantation in the body. |
| priorityDate |
1997-12-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |